Metacam 40 mg/ml - Solution for injection (cattle, horses)
Metacam 40 mg/ml - Solution for injection (cattle, horses)
Authorised
- Meloxicam
Product identification
Medicine name:
Metacam 40 mg/ml - Solution for injection (cattle, horses)
Active substance:
- Meloxicam
Target species:
-
Cattle
-
Horse
Route of administration:
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
MeloxicamPresentation_strength:40 mg Reference:Ph.Eur. Index:0
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Cattle
-
Meat and offal15day15 days
-
Milk5day5 days
-
-
Horse
-
Meat and offal5day5 days
-
-
-
Subcutaneous use
-
Cattle
-
Meat and offal15day15 days
-
Milk5day5 days
-
-
Horse
-
Meat and offal5day5 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AC06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Available in:
-
France
-
Spain
Package description:
- Packaging:Vial (glass), Package_size:12 vials, Content:50 ml
- Packaging:Vial (glass), Package_size:12 vials, Content:100 ml
- Packaging:Vial (glass), Package_size:1 vial, Content:100 ml
- Packaging:Vial (glass), Package_size:1 vial, Content:50 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- LABIANA LIFE SCIENCES, S.A.
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 5/12/2024
Bulgarian (PDF)
Published on: 5/12/2024
Croatian (PDF)
Published on: 5/12/2024
Czech (PDF)
Published on: 5/12/2024
Danish (PDF)
Published on: 5/12/2024
Dutch (PDF)
Published on: 5/12/2024
Estonian (PDF)
Published on: 5/12/2024
Finnish (PDF)
Published on: 5/12/2024
French (PDF)
Published on: 5/12/2024
German (PDF)
Published on: 5/12/2024
Greek (PDF)
Published on: 5/12/2024
Hungarian (PDF)
Published on: 5/12/2024
Icelandic (PDF)
Published on: 5/12/2024
Italian (PDF)
Published on: 5/12/2024
Latvian (PDF)
Published on: 5/12/2024
Lithuanian (PDF)
Published on: 5/12/2024
Maltese (PDF)
Published on: 5/12/2024
Norwegian (PDF)
Published on: 5/12/2024
Polish (PDF)
Published on: 5/12/2024
Portuguese (PDF)
Published on: 5/12/2024
Romanian (PDF)
Published on: 5/12/2024
Slovak (PDF)
Published on: 5/12/2024
Slovenian (PDF)
Published on: 5/12/2024
Spanish (PDF)
Published on: 5/12/2024
Swedish (PDF)
Published on: 5/12/2024
ema-puar-v33-metacam-ii0084-en.pdf
English (PDF)
Download Published on: 12/08/2025
ema-puar-v33-metacam-vra0151g-en.pdf
English (PDF)
Download Published on: 23/05/2024
ema-puar-metacam-v-033-par-en.pdf
English (PDF)
Download Published on: 17/03/2023
ema-puar-metacam-novem-var-ws-0264-en.pdf
English (PDF)
Download Published on: 17/03/2023
ema-puar-metacam-v-033-var-ii-0127-en.pdf
English (PDF)
Download Published on: 17/03/2023
ema-puar-metacam-v-033-var-x-0107-en.pdf
English (PDF)
Download Published on: 17/03/2023
ema-puar-metacam-v-033-var-x-0119-en.pdf
English (PDF)
Download Published on: 15/03/2023
